NCT00574223View on ClinicalTrials.gov

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Perennial Allergic RhinoconjunctivitisHouse Dust Mite Allergy
Interventions
DRUG

CYT005-AllQbG10 (combination of house dust mite allergen extract with CYT003-QbG10)

subcutaneous injections at 8 visits

DRUG

House dust mite allergen extract in combination with CYT003-QbG10-placebo

subcutaneous injections at 8 visits

Trial Locations (1)

CH-8952

Cytos Biotechnology (Sponsor's Headquarter), Schlieren

Sponsors
All Listed Sponsors
lead

Cytos Biotechnology AG

INDUSTRY